Literature DB >> 25573679

Psychosocial distress in patients with thyroid cancer.

Luke Buchmann1, Shaelene Ashby2, Richard B Cannon3, Jason P Hunt2.   

Abstract

OBJECTIVE: The purpose of this study is to evaluate levels of psychosocial distress in thyroid cancer patients. An analysis of factors contributing to levels of distress is included. STUDY
DESIGN: Individual retrospective cohort study.
SETTING: Head and neck cancer clinic at the Huntsman Cancer Institute. SUBJECTS AND METHODS: A total of 118 newly diagnosed thyroid cancer patients were included in the study. Univariate and multivariate analyses evaluated levels of and factors contributing to distress.
RESULTS: Almost half (43.3%) of patients had significant distress. Those with self-reported psychiatric history, use of antidepressant medication, and history of radiation treatment had higher levels of distress. On multivariate analysis, patient endorsement of emotional issues predicted a higher distress level.
CONCLUSIONS: Thyroid cancer patients have high distress levels. Identification of thyroid cancer patients with high distress levels is important to offer additional support during cancer therapy. © American Academy of Otolaryngology—Head and Neck Surgery Foundation 2015.

Entities:  

Keywords:  anxiety; depression; oncology; psychosocial distress; thyroid cancer

Mesh:

Year:  2015        PMID: 25573679     DOI: 10.1177/0194599814565761

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  15 in total

1.  Evaluating the projected surgical impact of reclassifying noninvasive encapsulated follicular variant of papillary thyroid cancer as noninvasive follicular thyroid neoplasm with papillary-like nuclear features.

Authors:  Rajshri Mainthia; Heather Wachtel; Yufei Chen; Elizabeth Mort; Sareh Parangi; Peter M Sadow; Carrie C Lubitz
Journal:  Surgery       Date:  2017-11-13       Impact factor: 3.982

Review 2.  Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: Historical Context, Diagnosis, and Future Challenges.

Authors:  Bin Xu; Giovanni Tallini; Ronald A Ghossein
Journal:  Endocr Pathol       Date:  2017-06       Impact factor: 3.943

3.  Reclassification as NIFTP: a Retrospective Review in a Single Institution with an Emphasis on Workload.

Authors:  Kevin O'Hare; E O'Regan; A Khattak; M L Healy; M Toner
Journal:  Endocr Pathol       Date:  2018-09       Impact factor: 3.943

4.  Study on the correlation between postoperative mental flexibility, negative emotions, and quality of life in patients with thyroid cancer.

Authors:  Jieshu Lv; Linlin Zhu; Xianmei Wu; Hongyun Yue; Xiaowei Cui
Journal:  Gland Surg       Date:  2021-08

Review 5.  Patient perception of receiving a thyroid cancer diagnosis.

Authors:  Catherine B Jensen; Susan C Pitt
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2021-10-01       Impact factor: 3.626

6.  Prevalence and predictors of psychological distress among patients with thyroid cancer during transitional period in China: a cross-sectional study.

Authors:  Jie Gao; Xin Wang; Li Zhang; Juan Li; Xuan Qin; Lan Wang; Jing Zhao
Journal:  Support Care Cancer       Date:  2022-06-21       Impact factor: 3.359

7.  Mental Health in Postoperative Thyroid Patients During the COVID-19 Pandemic.

Authors:  Shijie Yang; Xiequn Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

8.  Same strategy for pitfalls of radiotherapy in different anatomical districts.

Authors:  Margherita Gobbo; Giulia Ottaviani; Katia Rupel; Francesca Ciriello; Aulo Beorchia; Roberto Di Lenarda; Serena Zacchigna; Matteo Biasotto
Journal:  Lasers Med Sci       Date:  2016-01-21       Impact factor: 3.161

9.  Pregnancy in papillary thyroid cancer survivors

Authors:  Kemal Beksaç; Fatih Aktoz; Gökçen Örgül; Hasan Tolga Çelik; A Seval Özgü-Erdinç; M Sinan Beksaç
Journal:  J Turk Ger Gynecol Assoc       Date:  2018-02-20

10.  Thyro-stress.

Authors:  Sanjay Kalra; Komal Verma; Yatan Pal Singh Balhara
Journal:  Indian J Endocrinol Metab       Date:  2017 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.